MD ANDERSON CANCER CENTER and Pfizer will collaborate in the development of immune-based approaches to cancer treatment, the first such agreement made through MD Anderson’s Moon Shots Program immunotherapy platform.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
